ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/19/2025
Back to search
Official data from USPTO
ADTHYZA (THYROID TABLETS, USP)
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
03/20/2025
Trademark type
Combined
Nice classes
5
Filing date
08/08/2022
Registration date
07/18/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/18/2023
Last transaction
03/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/21/2023
First use in commerce
02/21/2023
Drawing code
3
Owner type
03
Owner location
Woburn, MA
Examiner
NKOJO, RHODA
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of two adjacent rounded triangle shapes with an ombre effect from teal to dark green, to the left of the word "ADTHYZA" in dark green, with the triangle shapes and capital "A" underlined with a bold purple line, and the words "(thyroid tablets, USP)" in purple underneath the word "ADTHYZA".
Holders and representatives
Holders
Azurity Pharmaceuticals, Inc.
Representatives
Elizabeth Fox KING & SPALDING
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of hypothyroidism
Publications
History of USPTO decisions and trademark events.
18 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/18/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/18/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/16/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/15/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/23/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/22/2023
IUAF
USE AMENDMENT FILED
05/01/2023
EISU
TEAS STATEMENT OF USE RECEIVED
05/01/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2023
PUBO
PUBLISHED FOR OPPOSITION
02/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2023
DOCK
ASSIGNED TO EXAMINER
01/10/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/30/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/28/2022
NWAP
NEW APPLICATION ENTERED
08/11/2022
Continuous trademark protection
Get notified about every new filing that threatens ADTHYZA (THYROID TABLETS, USP) or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.